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Alveologenesis is the ﬁnal step of lung maturation, which subdivides the alveolar region of the lung into
smaller units called alveoli. Each of the nascent dividers serves as a new gas-exchange surface, and
collectively they drastically increase the surface area for breathing. Disruption of alveologenesis results in
simpliﬁcation of alveoli, as is seen in premature infants diagnosed with bronchopulmonary dysplasia
(BPD), a prevalent lung disease that is often associated with lifelong breathing deﬁciencies. To date, a
majority of studies of alveologenesis rely on two-dimensional (2D) analysis of tissue sections. Given that
an overarching theme of alveologenesis is thinning and extension of the epithelium and mesenchyme to
facilitate gas exchange, often only a small portion of a cell or a cellular structure is represented in a single
2D plane. Here, we use a three-dimensional (3D) approach to examine the structural architecture and
cellular composition of myoﬁbroblasts, alveolar type 2 cells, elastin and lipid droplets in normal as well
as BPD-like mouse lung. We found that 2D ﬁnger-like septal crests, commonly used to depict growing
alveolar septae, are often artifacts of sectioning through fully established alveolar walls. Instead, a more
accurate representation of growing septae are 3D ridges that are lined by platelet-derived growth factor
receptor alpha (PDGFRA) and alpha smooth muscle actin (α-SMA)-expressing myoﬁbroblasts, as well as
the elastin ﬁbers that they produce. Accordingly in 3D, both α-SMA and elastin were each found in
connected networks underlying the 3D septal ridges rather than as isolated dots at the tip of 2D septal
crests. Analysis through representative stages of alveologenesis revealed unappreciated dynamic changes
in these patterns. PDGFRA-expressing cells are only α-SMA-positive during the ﬁrst phase of alveolo-
genesis, but not in the second phase, suggesting that the two phases of septae formation may be driven
by distinct mechanisms. Thin elastin ﬁbers are already present in the alveolar region prior to alveolo-
genesis, suggesting that during alveologenesis, there is not only new elastin deposition, but also ex-
tensive remodeling to transform thin and uniformly distributed ﬁbers into thick cables that rim the
nascent septae. Analysis of several genetic as well as hyperoxia-induced models of BPD revealed that the
myoﬁbroblast organization is perturbed in all, regardless of whether the origin of defect is epithelial,
mesenchymal, endothelial or environmental. Finally, analysis of relative position of PDGFRA-positive
cells and alveolar type 2 cells reveal that during alveologenesis, these two cell types are not always
adjacent to one another. This result suggests that the niche and progenitor relationship afforded by their
close juxtaposition in the adult lung may be a later acquired property. These insights revealed by 3D
reconstruction of the septae set the foundation for future investigations of the mechanisms driving
normal alveologenesis, as well as causes of alveolar simpliﬁcation in BPD.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
A cardinal goal of lung development is to produce sufﬁcient
surface area for gas exchange. Prenatally, the lung undergoes over
20 generations of branching, which is followed by formation ofsaccules at the distal ends of branches. These saccules will then be
subdivided into gas-exchange units called alveoli. Alveoli forma-
tion, or alveologenesis, occurs primarily postnatally with 90% of
human alveoli and all of mouse alveoli forming after birth (Churg
et al., 2005). In mice, alveologenesis initiates at postnatal day 4
(P4), peaks at P7 and ends at P36 (Mund et al., 2008; Schittny
et al., 2008). In human, alveologenesis initiates at 32 weeks of
gestation, and continues until ages 2 through 8, depending on
estimation (Dunnill, 1962; Langston et al., 1984; Thurlbeck, 1982).
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alveoli which constitute approximately 75 m2 alveolar surface area
(Ochs et al., 2004; Rhoades and Bell, 2012). Alveologenesis is cri-
tical for proper lung function, but the underlying mechanisms
governing this process are poorly understood.
Among all steps of lung development, alveologenesis is the
most frequently perturbed process in lung diseases. Disruptions in
alveolar formation are often observed in very low birth weight
premature infants resulting in a life-long disease called broncho-
pulmonary dysplasia (BPD) (Husain et al., 1998; Jobe, 1999). Due to
a halt in lung maturation and inability to breathe on their own,
these infants need to be ventilated with positive-pressure oxygen,
which further damages alveolar structures (Askie et al., 2003; Jobe
and Bancalari, 2001; Saugstad, 2003; Vento et al., 2009). BPD is
often studied using a mouse models by treating neonatal wild-
type pups with hyperoxia. However, much still need to be learned
about the complex molecular and cellular causes of alveolar sim-
pliﬁcation in BPD.
Alveologenesis requires spatial and temporal coordination of
multiple specialized cell types (Greer et al., 2014). In the alveolar
epithelium, alveolar epithelial type1 cells (AEC1s) line the alveolus
and form the air-blood barrier. Alveolar epithelial type 2 cells
(AEC2s) secrete surfactants, which reduce surface tension and
prevent collapse of the alveolar wall upon expiration. It is believed
that the alveolar mesenchyme contains multiple types of ﬁbroblast
populations. While all are poorly characterized, two of which are
loosely deﬁned as myoﬁbroblasts, which exhibit contractile
properties and produce elastin, and lipoﬁbroblasts, which contain
lipid droplets (Adler et al., 1989; Brody and Kaplan, 1983; Kapanci
et al., 1974; McGowan and Torday, 1997; Mitchell et al., 1990; Re-
han et al., 2006). The microvasculature of the lung includes both
the capillary network, through which blood is oxygenated, and the
lymphatic network through which excess ﬂuid is drained. Most of
the aforementioned alveolar cell types are required for septation.
However, little is known about the speciﬁc role of each population
and how they coordinate their function to achieve alveologenesis.
In this study, we focused on the alveolar myoﬁbroblasts, as they
are thought to play a key role in septation (Boström et al., 1996;
Lindahl et al., 1997; McGowan et al., 2008). Myoﬁbroblasts are
deﬁned by their expression of alpha-smooth muscle actin (α-SMA,
also termed ACTA2), which is thought to drive myoﬁbroblast
contraction observed in vitro (Adler et al., 1989; Arora et al., 1999;
Chen et al., 2012; Leslie et al., 1990; McGowan et al., 2008; Sanders
et al., 2007). Myoﬁbroblasts are believed to be the primary pro-
ducer of elastin, an extracellular matrix molecule (Boström et al.,
1996; Lindahl et al., 1997). Elastin ﬁber elasticity allows the lung to
stretch during inhalation and recoil afterwards.
Many questions remain in regard to myoﬁbroblast differentia-
tion and function. It is generally believed that Pdgfra is a marker of
myoﬁbroblast precursors and myoﬁbroblasts. At the end of sac-
culation and in preparation for alveologenesis (P0-P3), PDGFRAþ
myoﬁbroblast precursors are believed to migrate from the saccule
openings distally around the saccule to future sites of septae in-
itiation. In Pdgfa-/- mutant, this migration does not occur and no
septae forms (Boström et al., 1996; Lindahl et al., 1997; McGowan
et al., 2008). While it is believed that PDGFA signaling is mediated
via PDGFRA, a similar failure of myoﬁbroblast precursor position-
ing phenotype has not been shown in any Pdgfrα mutants that
have been analyzed (Boström et al., 2002; McGowan and McCoy,
2014, 2013). During alveologenesis, it is proposed that PDGFRAþ
myoﬁbroblasts migrate from the base of the saccule towards the
lumen (Burri, 1984; Lindahl et al., 1997; Prodhan and Bernard Ki-
nane, 2002). As a result, myoﬁbroblasts are found at the alveolar
entrance ring (AER) which rims the nascent septal cup (McGowan
et al., 2008). However, it remains unclear what propels the myo-
ﬁbroblasts into the lumen.Current models of alveologenesis have focused on two-di-
mensional (2D) sections of the alveoli. These studies have identi-
ﬁed structures called secondary septal crests, which are ﬁnger-like
protrusions into the lumen thought to be the growing structures
that subdivide saccules into alveoli (Amy et al., 1977; Burri, 1984;
Zeltner and Burri, 1987). Since these crests often contain elastin, it
is hypothesized that elastin deposition into crest tips drives sep-
tation (Boström et al., 1996; Burri and Weibel, 1977; Burri, 1984;
Emery, 1970; Noguchi et al., 1989). However, when the luminal
surface of the alveolar region was viewed by 3D synchrotron-ra-
diation x-ray tomography, no ﬁnger-like protrusions were ob-
served (Mund et al., 2008; Schittny et al., 2008). Instead, long
ridges appear to rise up from the saccule walls into the airspace.
These results led us to question how the 2D septal crest corres-
ponds to the structures observed during alveolar formation in 3D.
Therefore, we sought to characterize the architecture and cellular
composition of the lung just before and during alveologenesis
using 3D reconstruction.2. Results
2.1. Alveolar “septal crests” are an artifact of 2D sectioning and 3D
septal ridges are lined with a network of α-SMA ﬁbers
To visualize alveoli in 3D throughout lung maturation, we im-
aged 70 μm lung slices immunostained for various alveolar cell
and matrix markers between P0 and P15, which precedes and
contains the peak window of alveologenesis (Mund et al., 2008;
Schittny et al., 2008). Staining for AEC1s with T1α antibody pro-
vided a clear outline of the alveolar architecture (Fig. 1). As ex-
pected, many septal crests were visible in 2D at P7, a peak stage of
alveologenesis (Fig. 1A–C). Nearly all septal crest tips exhibited α-
SMA expression (Fig. 1A–C). In serial optical sections, we noticed
that septal crests joined to form continuous alveolar walls in ad-
jacent optical planes (Fig. 1A–C, arrows). In fact, most septal crests
viewed in one optical plane converged into continuous alveolar
walls only 2–5 μm lower. When the 2D series was rendered in 3D,
alveoli appeared as cup-like structures lined by AEC1s with an
open side facing the air-ﬁlled lumen. There were no visible ﬁnger-
like septal crests (Fig. 1D and E, Movie S1). Rather, many pre-
viously identiﬁed septal crests were in fact part of an existing fully
grown septal ridge, where the optical section had transected the
ridge and exposed the cut surface (Fig. 1D and E, arrows, also as
diagrammed in Fig. 7A–C). Thus, rather than septa crests in 2D,
septal ridges in 3D are more accurate representations of growing
surfaces that subdivide the alveoli. Interestingly, we found that
septal ridges, some in the form of circular rims at the alveolar
entrance ring (AER), were all lined by α-SMA ﬁbers at P7.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.11.017.
2.2. α-SMA is expressed in a restricted window during
alveologenesis
Since myoﬁbroblasts are thought to drive alveologenesis, we
next used α-SMA as a marker and imaged these cells prior to and
during alveologenesis in 3D. In addition, we used Pdgfra as it has
been implicated as a marker for both the myoﬁbroblast precursor
as well as for myoﬁbroblasts (Boström et al., 1996; McGowan et al.,
2008; Perl and Gale, 2009). We carried out the α-SMA antibody
staining in lungs from Pdgfra H2B-GFP/þ mice (hereafter PDGFRA-
GFP), where H2B-eGFP is expressed from the endogenous Pdgfra
locus, labeling the nuclei (Hamilton et al., 2003; Kimani et al.,
2009). At P0, prior to the initiation of alveologenesis, α-SMA ﬁbers
were observed in a subset of the PDGFRA-GFPþ cells that
Fig. 1. Septal crests represent sections through existing alveolar walls. (A–C) 2D images of individual optical sections of 75 mm lung slice with α-SMA and T1α staining.
Optical section in (A) is 3 um above section in (B) and image (B) is 2 um above optical section in (C). Arrows (i–iv) indicate septal crests that converge into closed alveolar
walls in another section plane. (D–E) Front and back views of 3D surface rendering of 50 um image stack which includes optical sections shown in (A–C) [see also Movie S1].
Arrows (i–iv) indicate alveolar walls in 3D that correspond to the 2D septal crests indicated in (A–C). (A–E) 40X magniﬁcation. All images in following ﬁgures are 3D
renderings unless otherwise speciﬁed.
Fig. 2. α-SMA is expressed in a restricted time window in alveoli. (A–C) Surface rendering of PDGFRA-GFP expression and α-SMA staining in alveolar region at stages P0, P7
and P15. (A) α-SMA ﬁbers surround saccules openings and arterioles at P0. Arrowheads indicate PDGFRA-GFPþ cells not surrounding saccules which do not express α-SMA at
P0. (B) All PDGFRA-GFPþ myoﬁbroblasts are associated with α-SMA ﬁbers surrounding alveoli at P7. (C) PDGFRA-GFPþ cells in the alveolar region do not express α-SMA at
P15. α-SMA is expression is still found surrounding terminal bronchioles (tb). (A–C) 40X magniﬁcation.
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low intensity in the PDGFRA-GFPþ cells dispersed throughout the
interstitial mesenchyme (Fig. 2A, Fig. S1A). Starting at P2, α-SMAﬁbers were detected in the alveolar interstitium (Fig. S2Ai).
At P7, α-SMAþ ﬁbers were observed in all PDGFRA-GFPþ cells,
both surrounding large saccule openings as well as around the
Fig. 3. Mouse models of disrupted alveolar formation exhibit altered α-SMA expression. (A–H) α-SMA staining (red) in alveolar region. (E–H) PDGFRA-GFP labels expressing nuclei.
(A–B) Pecam-1mutants, which exhibit impaired alveologenesis due to endothelial defects, shows increased α-SMA expression around alveoli at P7. (C–D) Shhcre;Etv4;5mutants, which
exhibit impaired alveologenesis due to epithelial defects, shows increased α-SMA expression and disorganized ﬁbers around alveoli at P7. (E–F)Tbx4cre;Pdgfra mutants, which exhibit
impaired alveologenesis due to myoﬁbroblast defects, shows increased α-SMA expression in an expanded domain at P12. (G–H) Hyperoxia-exposed mice, which mimic alveolar
defects observed in human BPD, exhibit α-SMA expression in alveolar region at P15 when normoxia-exposed alveoli no longer express α-SMA.
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Fig. 4. Elastin ﬁber matrix is present at birth and undergoes remodeling during alveologenesis. (A–C) Surface rendering of PDGFRA-GFP expression and elastin staining in
alveolar region at stages P0, P7 and P15. (A) Complex elastin ﬁber matrix is established by P0. All PDGFRA-GFPþ cells appear to be associated with elastin ﬁbers. (B) By P7,
elastin matrix has been remodeled to form tight bundles and are preferentially associated with the PDGFRA-GFP cells surrounding the AER. (C) By P15, the elastin ﬁber
matrix is more complex with additional small ﬁbers. (A–C) 40X magniﬁcation.
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(Fig. 2B, S1B, S2Bi). Approximately 3–7 PDGFRA-GFPþ myoﬁbro-
blasts surround each alveolus with α-SMA ﬁbers that appear to
encircle the AER (also as diagrammed in Fig. 7E). It is interesting
that no gaps were clearly visible in these α-SMAþ rings, even
though α-SMA ﬁbers are contained within myoﬁbroblast cells, and
presumably are not continuous across cell-cell junctions (Fig. 2B,
S2Bi, Movie S2). This suggests that myoﬁbroblasts may form
elongated cytoplasmic protrusions and tight or overlapping con-
nections to establish a continuous loop around the AER. Further-
more, these rings appear interconnected with each other, giving
rise to a “ﬁshnet”-like α-SMA network.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.11.017.
Immunostaining showed that myoﬁbroblasts also express
SM22 (also termed Transgelin), another smooth muscle marker
(Fig. S2Bii, Biii). At P7, SM22 staining was present throughout the
cytoplasm of myoﬁbroblasts, overlapping with both α-SMA ﬁbers
and PDGFRA-GFPþ nuclei (Fig. S2Bii, Biii). SM22 staining, like α-
SMA staining, showed that myoﬁbroblasts are tightly connected
forming rings around each alveolus at P7. Slightly lower intensity
of α-SMA ﬁbers continue to be detected in all PDGFRA-GFPþ cells
through P12, consistent with published ﬁndings (McGowan et al.,
2008) (Fig. S2Avii).
By P15, no α-SMA ﬁbers were present in the alveolar region
while abundance of PDGFRA-GFPþ nuclei remain (Fig. 2C and
S1C). α-SMAþ smooth muscle is only observed surrounding
proximal airways, including terminal bronchioles (Fig. 2C). SM22
staining intensity is also reduced and becomes uneven, in contrast
to that at P7 (Fig. S2D). In the adult lung sampled at P40, α-SMA
staining intensity continues to be low in the alveolar region while
PDGFRA-GFPþ nuclei remain abundant (Fig. S1D). The temporal
changes in α-SMA staining intensity are corroborated by quanti-
tative RT-PCR (qRT) and western-blot data measuring the levels of
α-SMA transcript as well as protein, respectively (Fig. S3). These
results suggest that the changes in staining intensity are due to
changes in expression level. We also analyzed general ﬁlamentous
actin (F-actin) pattern using phalloidin staining at the same stages
(Fig. S1E–H). As expected, phalloidin staining is detected in all cells
in the alveolar region. There appear to be a slight overall down-
regulation of intensity and fewer labeled long ﬁbers at P15 and
P40 compared to earlier stages. These results suggest that the
myoﬁbroblast characteristic as deﬁned by α-SMA staining is atransient feature of PDGFRA-GFPþ alveolar ﬁbroblasts.
2.3. Increased α-SMA ﬁbers represent a general stress response to
impaired lung maturation
To determine the role of myoﬁbroblasts in the pathogenesis of
impaired alveolar formation, we characterized myoﬁbroblasts in
several models using the 3D approach. We assessed genetic mu-
tant models with primary defects in each of the major cell lineages
of the lung—the epithelium, the endothelium and the myoﬁbro-
blasts. In addition, we assessed myoﬁbroblasts in wild-type mice
treated with hyperoxia from birth, a commonly used model of BPD
(Fig. 3).
For the endothelial mutant, we used a null allele of Pecam-1,
which encodes a cell adherens junction protein expressed on the
surface of endothelial cells. Pecam1 mutant mice show impaired
alveologenesis as a result of defects in endothelial cell migration,
but not cell proliferation or survival (DeLisser et al., 2006) (Fig. 3A
and B). For the epithelial mutant, we used the Shhcre;Etv4;5 mu-
tant, where two paralogous transcription factor genes downstream
of FGF pathway, are inactivated in the epithelium by Shhcre
(Fig. 3C and D). These mutant mice show defects in epithelial
branching followed by saculation and alveologenesis as a result of
altered gene expression in the epithelium (Herriges et al., 2015).
For the mesenchymal mutant, we used the Tbx4cre;PdgfraGFP/ﬂ
mutant, where Pdgfra, the receptor which is not only a marker, but
also is essential for myoﬁbroblast function, is inactivated in the
mesenchyme using one Pdgfra allele where GFP has been knocked
into the endogenous locus disrupting gene function, and one
ﬂoxed Pdgfra allele inactivated by Tbx4cre in the lung mesenchyme
(Hamilton et al., 2003; Klinghoffer et al., 2002; McGowan and
McCoy, 2013; Naiche et al., 2011) (Fig. 3E and F). It has been shown
previously, and we conﬁrmed that Tbx4cre has widespread activity
in the lung mesenchyme (Fig. S4) (Naiche et al., 2011). This allelic
combination allows us to both inactivate Pdgfra in the mesench-
yme and simultaneously visualize the remaining myoﬁbroblasts.
Tbx4cre;PdgfraGFP/ﬂ mutants show a strong alveolar simpliﬁcation
phenotype similar to that observed when Pdgfra is inactivated in
the smooth muscle cells by Transgelin-cre (McGowan and McCoy,
2013) (Fig. S5). For the hyperoxia exposure model, we placed 1-day
old PdgfraGFP/þ pups into a 75% oxygen environmental chamber for
2 weeks and then analyzed lungs at P15 (Fig. 3G and H). Similar
treatment has been shown to mimic features of human BPD
Fig. 5. Mouse models of impaired alveologenesis exhibit disorganized elastin matrices. (A–F) Elastin staining (red) in alveolar region. (E–F) PDGFRA-GFP labels the nuclei of
expressing cells. (A–B) Tbx4cre;Pdgframutants show mesh of elastin ﬁbers lacking thick bundles at P12. (C–D) Shhcre;Etv4;5mutants show disorganized thin tortuous elastin
ﬁbers at P7. (E–F) Hyperoxia-exposed lungs show patches of dense elastin mesh (see top region and bottom right region of image), while other alveolar regions exhibit
apparently normal elastin bundles at P15.
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Fig. 6. Myoﬁbroblast relationship to AEC2s and lipid droplets. (A) PDGFRA-GFPþ myoﬁbroblasts at P7 in alveoli, outlined by T1α staining of AEC1s [see also Movie S5].
(B) AEC2s at P7 in T1α outlined alveoli [see also Movie S6]. (C) Quantiﬁcation of mean myoﬁbroblasts/alveolus and AEC2s/alveolus at P7. PDGFRA-GFPþ myoﬁbroblasts per
alveolus: 6.87 cells72.47. SPCþ AEC2s per alveolus: 3.00 cells70.94. n¼10 lungs each, minimum of 50 alveoli quantiﬁed. (D-F) PDGFRA-GFP expression and SPC staining in
alveolar region at stages P0, P7 and P15 [see also Movies S7–S9]. Arrowheads indicate AEC2s that are not in direct apposition to PDGFRA-GFPþ cell. (G) SPC and α-SMA
staining at P7 [see also Movie S10]. (H,I) PDGFRA-GFP expression and anti-PDGFRβ staining in alveolar region at P7. Boxed area in H is magniﬁed in I. Arrows indicate
PDGFRA-GFP and PDGFRβ double positive cells, arrowheads indicate PDGFRβ single positive cells, asterisks indicate PDGFRA-GFP single positive cells. (J,K) PDGFRA-GFP
expression and LipidTOX staining of lipid droplets at P0 and P15 [see also Movie S11 and S12]. A subset of PDGFRA-GFPþ cells are associated with lipid droplets at P0 (J),
while all PDGFRA-GFPþ cells appear closely associated with lipid droplets by P15 (K). Arrowheads in (J) indicate PDGFRA-GFPþ cells that are not closely associated with lipid
droplets.
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We were surprised to ﬁnd that all models exhibited increased
and disorganized α-SMA ﬁber staining compared to normal con-
trols (Fig. 3A–H). In the hyperoxia-exposed lungs, as we analyzed
the lungs after the two-week regime, we examined them at a stage
when α-SMA is no longer expressed in the alveolar region in mice
raised in normoxic conditions (P15). In hyperoxia-exposed mice,
however, α-SMA continued to be detected, although the number
and distribution of PDGFRA-GFP expressing myoﬁbroblasts ap-
peared normal (Fig. 3G and H). This ﬁnding that the increase and
disorganization of α-SMA ﬁbers can be observed in the distinct
mutants and following hyperoxia treatment suggest that the
myoﬁbroblast phenotype is a general response to disruptions of
lung maturation, and may be the common effector leading to the
shared outcome of alveoli simpliﬁcation.
PDGFA signaling has been proposed to provide a migratory
signal for myoﬁbroblasts distribution around the saccule in pre-
paration for septae formation (Boström et al., 1996; Lindahl et al.,
1997; McGowan et al., 2008). This is based on the ﬁnding that in
Pdgfa mutants, Pdgfra-expressing myoﬁbroblast precursor cells are
stalled at the openings of the saccules, and are not able to migrate
into the saccules. As the principle PDGFA receptor is PDGFRA, we
addressed whether conditional inactivation of Pdgfra in the lung
mesenchyme would lead to a similar defect as the ligand mutant.
In Tbx4cre;Pdgfra mutant lungs, PDGFRA-GFPþ myoﬁbroblasts
appeared widely distributed throughout the alveolar region
(Fig. 3E and F, S6). We did not observe any preferential clustering
of myoﬁbroblasts either near saccule openings, or at the bases of
alveoli, suggesting that there is no defect in myoﬁbroblast dis-
tribution in this receptor mutant.
2.4. Elastin ﬁber network is established prior to alveologenesis and
undergoes remodeling, not just de novo deposition, during
alveologenesis
Since myoﬁbroblast deposition of elastin is viewed as a critical
component of septation, we characterized the dynamic changes of
the elastin ﬁber matrix in 3D (Boström et al., 1996; Burri and
Weibel, 1977; Burri, 1984; Emery, 1970; Noguchi et al., 1989). We
were surprised to ﬁnd that at birth, PDGFRA-GFPþ cells have al-
ready established a complex elastin ﬁber network that not only
surrounds saccules but also is distributed throughout the inter-
stitium (Fig. 4A). All PDGFRA-GFPþ cells appear to be closely as-
sociated with elastin ﬁbers at P0, consistent with the possibility
that they are the primary elastin producing cells. By P7, the elastin
network appears signiﬁcantly remodeled with fewer thin ﬁbers
and a tighter localization of elastin bundles speciﬁcally encircling
alveolar openings (Fig. 4B, S2Biv, Movie S3). At this stage, elastin
and α-SMA ﬁbers formed closely parallel networks (Fig. S6Aiii, Avi,
Aix, C, Movie S4), suggesting that myoﬁbroblasts may drive elastin
remodeling. By P15, unlike the disappearance of α-SMA, the
elastin network persists, and additional thin ﬁbers have been ad-
ded to the alveolar region generating an increasingly complex
network (Fig. 4C). These observations suggest that rather than
being laid down by myoﬁbroblasts at the onset of alveologenesis,
the elastin network was present prior to alveologenesis initiates,
and was remodeled into organized scaffolds for nascent septae.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.11.017.
2.5. Disorganized elastin network is often, but not always associated
with impaired alveologenesis
To determine if altered elastin matrix is associated with de-
fective alveologenesis, we analyzed our mutant models and the
hyperoxia model of BPD (Fig. 5). Elastin staining in Pecam-1mutants was similar to controls (data not shown). In contrast,
Shhcre;Etv4;5 and Tbx4cre;Pdgfra mutant lungs as well as hyper-
oxia-exposed lungs all exhibited a disorganized elastin ﬁber net-
work, in interestingly distinct patterns from each other (Fig. 5A–F).
In Shhcre;Etv4;5 mutants, ﬁbers were thin, tortuous and unraveled
in all regions (Fig. 5A and B). In Tbx4cre;Pdgfra mutants, ﬁbers
formed a diffused mesh with minimal organization in all regions
(Fig. 5C and D). Hyperoxia-exposed lungs showed patches of dense
elastin mesh, with normally remodeled thick bundles in other
regions (Fig. 5E and F). These data suggest that alterations in
elastin ﬁber remodeling are often associated with impairments in
alveologenesis.
2.6. Relationship between PDGFRA-GFPþ ﬁbroblasts, AEC2s, peri-
cytes and lipids in the alveolus
In the adult lung, PDGFRA-GFPþ cells, particularly those with
high levels of GFP expression, reside adjacent to AEC2s, and have
been suggested to serve as a stem cell niche for AEC2s (Barkauskas
et al., 2013). In vitro culture experiments show that addition of
epithelial cells to fetal lung mesenchyme drives up 3D septae-like
structures with AEC2s in proximity to myoﬁbroblasts (Greer et al.,
2014). We sought to address whether a close relationship exists
between these two cell types endogenously during development
of alveoli in 3D. First, we assessed the numbers of each cell type
per alveolus at P7 (Fig. 6A–C). There were on average 7 PDGFRA-
GFPþ ﬁbroblasts (6.8772.47 cells) per alveolus. Approximately
69% of the nuclei of these cells residing near the AER, similar to
previous estimation (Fig. 6A, C, Movie S5) (McGowan et al., 2008).
For AEC2s, quantiﬁed by SPC staining, on average 3 cells
(3.0070.94 cells) were observed in each alveolus, and there is no
bias of localization near the AER (Fig. 6B and C, Movie S6). Thus,
the ratio of AEC2s to PDGFRA-GFPþ ﬁbroblasts per alveolus is
approximately 1: 2.3 at P7.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.11.017.
Next, we sought to determine whether a spatial relationship
exists between these two cell types during development in 3D. At
P0, P7 and P15, AEC2s were sometimes observed in close proxi-
mity to not only high PDGFRA-GFPþ cells, but also low PDGFRA-
GFP cells (Fig. 6D–F, Movies S7-S9). However, AEC2s not sharing a
close spatial relationship with PDGFRA-GFPþ cells were also ob-
served at all three stages (Fig. 6D–F, arrowheads, Movies S7–S9).
Since PDGFRA-GFPþ only labels the nuclei of these ﬁbroblasts, we
also assessed whether AEC2s are closely associated with the cy-
toplasmic extensions of ﬁbroblasts. We used α-SMA to label ex-
tensions of ﬁbroblasts, which we found is expressed by all
PDGFRA-GFPþ cells at P7 (Fig. 2B). AEC2s did not appear to share a
pronounced spatial relationship with α-SMAþ ﬁbers at P7, al-
though the two labels were sometimes observed near one another
(Fig. 6G, Movie S10).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.11.017.
We also addressed the relationship between PDGFRA-GFPþ
expression and PDGFRβ expression patterns in the alveoli. The
latter has been implicated as a marker for pericytes. Comparison of
GFP and anti-PDGFRβ antibody staining at P7 showed that there
are cells with double labeling, and cells with each of the single
labeling, suggesting that these two markers show overlapping but
non-identical expression patterns (Fig. 6H and I).
Finally, in the adult lung, high PDGFRA-GFP ﬁbroblasts are
thought to represent a population of lipid droplet containing ﬁ-
broblasts, referred to as lipoﬁbroblasts (Barkauskas et al., 2013;
Chen et al., 2012). Furthermore, lipoﬁbroblasts have been sug-
gested to transfer lipids to AEC2s, which can be used for surfactant
production (Gewolb and Torday, 1995; Schultz et al., 2002; Torday
Fig. 7. A schematic of alveologenesis. (A) At birth, prior to alveolar formation, the distal-most lung structures are saccules (shown as circular buds) which form off of
terminal bronchioles. Arrows indicate saccule openings. (B) During the peak phase of alveologenesis (P4-P12), α-SMA (in red) and closely associated elastin matrices (not
shown) is expressed in an organized network, mimicking a “ﬁshnet” pattern in the alveolar region. Peach-colored hemisphere represents epithelial lining of a saccule. Dotted
blue circle outlines an alveolar entrance ring (AER) that is underlined by α-SMA. (C) A slice containing several alveoli. Septal ridges (arrowheads) are lined by α-SMA ﬁbers (in
red) and closely associated elastin ﬁbers (not shown). Top dark line outline a possible cut 2D view with septal crests (asterisks) that are a result of a section through fully
grown septal walls (arrows). (D) Increase and disorganization in α-SMA (red) and elastin matrices (not shown) transforms “ﬁshnet” into “cheese cloth” and would prevent
relative rise of ridges into the lumen, thereby impair alveoli formation. (E) At the height of septae formation (P4-12), PDGFRA-GFPþ (green) myoﬁbroblasts form a ring at the
AER, where they express α-SMA ﬁbers (red) and deposit elastin ﬁbers (blue). These cells may contract as they drive in new septae, meanwhile remodeling the matrix to
stabilize newly formed structures.
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contents of PDGFRA-GFPþ alveolar ﬁbroblasts using the lipid
droplet dye LipidTOX (Fig. 6H and I). At P0, lipid droplet containing
cells were observed in the future alveolar region (Fig. 6H, Movie
S11). However, many PDGFRA-GFPþ ﬁbroblasts were not closely
associated with lipid droplets (Fig. 6H, arrowheads). By P15 the
overall lipid content within the alveolar region appeared to be
greatly increased (Fig. 6I, Movie S12). Surprisingly, nearly every
PDGFRA-GFPþ cell, not just the high GFP cells, contained
LipidTOXþ lipid droplets, in contrast to the ﬁnding in the adult
lung (Barkauskas et al., 2013). These data raise the possibility that
PDGFRA-GFPþ ﬁbroblasts undergo a developmental shift to in-
crease lipid droplet production during alveologenesis.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.11.017.3. Discussion
Alveologenesis and the cells involved have been widely studied
in 2D. However, few have studied the process in 3D over time
(McGowan et al., 2008; Mund et al., 2008; Schittny et al., 2008).
We reasoned that 3D reconstruction is essential for full re-
presentation of the cellular architecture, given the extensive
thinning and spreading of cells after birth. In order to preserve
alveolar structures, we imaged thick vibratome sections, which
required minimal processing compared to other methods (parafﬁn
sectioning, cryosectioning, plastic sectioning). Combining genetic
labeling, immunoﬂuorescent staining, confocal optical sectioning,
and 3D reconstruction approaches allowed us to visualize the in-
tricate networks of α-SMA and elastin matrices, as well as the
spatial relationship between cell populations.
Our 3D images revealed that septal crests, the ﬁnger-likeprotrusions commonly labeled in 2D to represent newly growing
septae, are often sections through existing alveolar walls
(Figs. 1 and 7). These results are consistent with the ﬁndings of
Mund et al., 2008 and Schittny et al., 2008, which used 3D syn-
chrotron X-ray tomography to visualize the architecture of the
luminal alveolar surface at multiple postnatal stages. Together, the
data indicate that a more accurate representation of the growing
septae are elongated ridges in 3D, which appear to rise up from
the base of alveolar cups to subdivide the alveoli into smaller
units. We have referred to these structures as septal ridges (Fig. 7).
Our 3D immunostaining results indicate that during new septae
formation, these ridges are underlined by α-SMA-positive myoﬁ-
broblasts and associated elastin ﬁbers.
How we deﬁne the growing septae has important implications
on how we apprehend the driving force for the alveologenesis
process. Based on the 2D septal crest deﬁnition, a model was put
forth which postulates that myoﬁbroblasts, after been scattered
around the alveolar wall, are repelled into the lumen, pushing in
the other cell types to form isolated protrusions (Burri, 1984;
Lindahl et al., 1997; Prodhan and Bernard Kinane, 2002). In con-
trast, the 3D view of septal ridge is more compatible with a hy-
pothesis ﬁrst put forth by J.L. Emery in 1970, where he stipulated
that the interlacing ﬁbers of the elastic tissue forms a complex
“ﬁshnet” around the alveolus (Emery, 1970). Our 3D images of not
just the elastin ﬁber, but also the myoﬁbroblast α-SMA are con-
sistent with the ﬁshnet pattern. This pattern evokes a very dif-
ferent model of alveologenesis, where the strings of the ﬁshnet
will underlie the future alveolar ridges. Through either active
constriction of the net and/or passive push by air pressure, the
septal walls not lined by the ﬁshnet will bulge out through the
pores rimmed by the strings, result in relative rise of the ridges
into the lumen (Fig. 7A and B). Compared to normal lung, the 3D
patterns observed from some of the BPD models, for example the
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organization of α-SMA and elastin ﬁbers. This converts the “ﬁsh-
net” into a “cheese cloth”, which would be ineffective at driving
the differential rise of the septal ridges from the septal walls
(Fig. 7D). Thus, the 3D patterns offer testable hypotheses for the
role of myoﬁbroblasts in not just normal alveologenesis, but also in
abnormal alveologenesis in BPD models.
3.1. Myoﬁbroblasts and α-SMA ﬁbers
In various tissues, including the lung, myoﬁbroblasts form actin
stress ﬁbers containing α-SMA, and contract (Adler et al., 1989;
Balestrini et al., 2012; Hinz, 2007; Kapanci et al., 1974; Leslie et al.,
1992; Noguchi et al., 1989; Tojkander et al., 2012). In cultured lung
myoﬁbroblasts, α-SMA level is directly related to contractile force
(Arora et al., 1999; Chen et al., 2012). In a pneumonectomy model
of adult lung regrowth and regeneration, α-SMA induction in
contractile ﬁbroblasts is thought to drive new septae formation
(Chen et al., 2012). Our results show that during alveologenesis,
the timing of α-SMA induction and localization under septal ridges
is consistent with a role for myoﬁbroblast contraction in septation
(Figs. 1 and 2). Furthermore, we found that at P7, all PDGFRA-GFPþ
cells express α-SMA. This suggests that at the height of septae
formation, these cells acquire contractile property regardless of
whether they belong to the PDGFRA-GFPþ bright or dim popula-
tions (Fig. 2B, S2Bi).
Induction of α-SMA expression is often referred to as a primary
step in myoﬁbroblast differentiation. In contrast to the expectation
that α-SMA stays on once activated, we found that α-SMA ﬁber is
detected in PDGFRA-GFPþ cells during a restricted time window
in development (P2–P12). Sustained or upregulated α-SMA is
associated with various impaired alveologenesis models, including
both genetic and hyperoxic-exposure models (Fig. 3). Furthermore,
others have shown that α-SMA expression can be reactivated
during lung regrowth and regeneration (Chen et al., 2012; Perl and
Gale, 2009). Together, these data suggest that rather than deﬁning
the fate of differentiated myoﬁbroblasts, α-SMA expression may
represent a contractile phenotype that the PDGFRAþ cell can
adopt transiently during septation, stress, or regeneration. Char-
acterizing the mechanisms that govern α-SMA appearance and
disappearance will enable future understanding of the dynamics
of myoﬁbroblast function.
In the Pdgfa mutant lung, PDGFRAþ cells stay in clumps at the
openings of saccules instead of being distributed around and
getting in position for septae formation (Lindahl et al., 1997;
McGowan et al., 2008; Perl and Gale, 2009). It was proposed that
PDGFA signaling is primarily mediated through PDGFRA (Boström
et al., 1996; Lindahl et al., 1997; McGowan et al., 2008). However,
in Tbx4cre;Pdgfra mutants, the PDGFRAþ cells are dispersed
throughout the alveolar region (Fig. 3E and F, S5). This difference
in phenotype is possibly due to either incomplete gene inactiva-
tion in the Pdgfra conditional mutants, or residual PDGFA signaling
through additional receptors such as PDGFRB which shows over-
lapping expression with PDGFRA (Fig. 6H and I).4. Elastin
Elastin is indispensable to lung maturation and function. Mice
homozygous for the elastin null allele exhibit dilated saccules due
to a defect in primary septae formation. The mutants die within a
few days after birth, prior to the onset of alveologenesis (Wendel
et al., 2000). Mice heterozygous for the elastin null allele show
reduced lung recoil and are more susceptible to alveolar destruc-
tion from cigarette smoke in an emphysema model (Shifren et al.,
2007). Furthermore, mice with mutations in variouselastinogenesis pathway components display simpliﬁcation of al-
veolar structures (reviewed in Wagenseil and Mecham (2007)).
Some models of alveologenesis have proposed that de novo elastin
deposition at the tips of septal crests is the driving force for the
formation of new septae (Boström et al., 1996; Burri, 1984; Emery,
1970; Noguchi et al., 1989). However, we observed that elastin ﬁ-
bers are already present at birth. A primary change in the elastin
matrix between birth and the peak of alveologenesis (P7) is re-
modeling of these thin, widely distributed elastin ﬁbers into
thicker, more localized bundles surrounding alveolar openings.
Addition of new ﬁbers also likely occurs, and continues following
the peak of alveologenesis (P7), thereby increasing the density
of the network as observed at P15 (Fig. 4C). The dynamic changes
in staining pattern is consistent with previous data that in the
lung, the expression of tropoelastin, the elastin monomer which is
the building block of elastin ﬁbers, decreases shortly after birth
prior to the onset of alveologenesis, and increases again starting at
P7, and peaks at P10–14 (Bruce and Honaker, 1998; Mariani et al.,
2002). Thus, controlled deposition and remodeling of the elastin
network likely work together to facilitate septae formation.
Interestingly, this remodeling of the elastic ﬁber network co-
incides with appearance of α-SMA in the alveolar region and thus
presumed contractility of myoﬁbroblasts. In other tissues, similar
scenarios have been shown where myoﬁbroblasts undergo a
contractile phase and exhibit stress ﬁber formation during extra-
cellular matrix and connective tissue remodeling (Hinz et al.,
2012; Pellegrin and Mellor, 2007). Therefore, we hypothesize that
the early elastin matrix established at birth provides a scaffold for
myoﬁbroblasts to adhere on as they drive in new septae. These
contractile myoﬁbroblasts may in turn remodel the matrix, as well
as deposit new elastin ﬁbers to rings surrounding the openings of
alveoli to stabilize the nascent structures (Fig. 7E).
This crosstalk between the contractile properties of myoﬁbro-
blasts and the mechanical properties of the ECM is also reﬂected in
the ﬁnding that in several of our mutant models and our hyper-
oxia-exposure model of impaired alveologenesis, there is both an
increases in α-SMA staining as well as disorganization of elastic
ﬁber matrices. Currently, it is unclear whether alterations in α-
SMA expression and elastic ﬁber organization are results of im-
paired lung maturation or are contributors to pathogenesis.
Nevertheless, disorganization of the elastin ﬁbers is of particular
relevance to BPD as reduced lung elastance, which leads to in-
creased effort to breathe, is a common feature of the disease.
4.1. Two waves of alveologenesis
In this study, we show that there are two phases of myoﬁbro-
blast behavior in alveologenesis. In the ﬁrst phase (P2-P14),
myoﬁbroblasts express α-SMAþ ﬁbers and the elastin network is
remodeled (Figs. 2, 4, S1). In the second phase (P15 and later),
there is no alveolar α-SMA while the elastic ﬁber matrix continues
to increase in complexity through addition of smaller intervening
ﬁbers. The timing of this transition correlates closely with that in a
two-wave model of alveologenesis (Boucherat et al., 2007; Mariani
et al., 2002; Mund et al., 2008; Schittny et al., 2008). It was deﬁned
that the ﬁrst wave involves rapid formation of new septal walls
and the second wave involves lifting of septae off existing walls
(Mund et al., 2008; Schittny et al., 2008). Our results provide clear
evidence indicating that the cellular mechanisms driving the two
waves of alveologenesis may be distinct.
4.2. Myoﬁbroblasts, lipoﬁbroblasts and AEC2s
Our observation is consistent with the notion that PDGFRAþ
cells show dynamic changes of characteristics in the early post-
natal period. At P0, prior to the onset of alveologenesis,
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pression (Fig. 2A) and only a few contain lipid droplets (Fig. 6J,
Movie S11). By P7, when alveolar formation is peaking, all
PDGFRA-GFPþ cells express α-SMA (Fig. 2B), thereby exhibiting a
myoﬁbroblast phenotype. Finally, by P15, PDGFRA-GFPþ cells no
longer express α-SMA (Fig. 2C) but all appear to be associated with
lipid droplets (Fig. 6K, Movie S12). These results are consistent
with previous ﬁndings (McGowan et al., 2008), and raise the
possibility that the PDGFRA-GFPþ population may differentiate
into myoﬁbroblasts with contractile-like properties during alveo-
logenesis and then later adopt a lipoﬁbroblast fate. However,
lineage-tracing experiments need to be conducted to determine if
the same cell population adopts the two different characteristics at
different time points.
In adult lungs, AEC2s can be found in close proximity to
PDGFRA-GFPþ high-intensity, but not low-intensity ﬁbroblasts
containing lipid droplets (Barkauskas et al., 2013). Additionally,
PDGFRA-GFPþ cells can promote proliferation and differentiation
of AEC2s into AEC1s in alveolosphere co-cultures that mimic al-
veolar structures. These ﬁndings led to the proposal that
PDGFRA-GFPþ lipoﬁbroblasts serve as a stem cell niche for AEC2s.
Our results show that at P7, the peak of alveolar development
when PDGFRA-GFPþ cells are primarily myoﬁbroblasts in char-
acter, only a subset of AEC2s are closely associated with
PDGFRA-GFPþ cells. The proximity of these cells increases by P15
when PDGFRA-GFPþ cells are no longer SMAþ , but have increased
in lipid content (Fig. 6D–F). Additionally, this close apposition can
be found regardless of PDGFRA-GFPþ intensity level, in contrast to
the selected association with high-intensity PDGFRA-GFPþ cells in
the adult. A further difference is that during normal development
there are approximately 2.3 PDGFRA-GFPþ cells for every AEC2 in
each alveolus (Fig. 6C), rather than the 20:1 ratio typically used in
alveolosphere co-culture experiments involving adult cells (Bar-
kauskas et al., 2013). It awaits to be tested if PDGFRA-GFPþ cells
provide a trophic effect for AEC2s during alveologenesis, similar to
their role in the adult lung. Furthermore, from epithelial and
mesenchymal cell co-culture experiments, it was proposed that
during alveologenesis, AEC2 cells may squeeze and repel myoﬁ-
broblasts toward the lumen, driving out new septae (Greer et al.,
2014). Our observations from the relative positioning of AEC2s and
PDGFRAþ myoﬁbroblasts are in line with this proposal.
Our ﬁndings from this study re-enforce the notion that the struc-
tural and cellular composition of the alveolus is more accurately re-
presented in 3D than in 2D. The alveologenesis process is also very
dynamic, thus multiple time points need to be analyzed to fully il-
lustrate normal or pathological conditions. Our results reveal that
myoﬁbroblasts are very sensitive to genetic and environmental per-
turbations, and disruption of their number and organization may in
turn prevent septal formation. A comprehensive understanding of the
dynamic alveologenesis process in 3D will ultimately reveal the
complex causes of neonatal diseases such as BPD.5. Experimental procedures
5.1. Animals and tissues
For wild-type studies, lungs were obtained from FVB mice be-
tween postnatal days 0 and 15. For analysis of PDGFRA-GFP, mice
heterozygous for the Pdgfra-H2B-GFP allele were used (Hamilton
et al., 2003; Klinghoffer et al., 2002). GFP is expressed from the
endogenous Pdgfra locus and the expression pattern recapitulates
endogenous expression of Pdgfra (Hamilton et al., 2003). Devel-
opment of heterozygous Pdgfra-GFP/þ mice was indistinguishable
fromwild-type mice. Pdgfra conditional knockouts were generated
by breeding together Tbx4cre (Naiche et al., 2011), PdgfraFlox(Tallquist and Soriano, 2003), and PDGFRA-GFP alleles to con-
ditionally inactivate Pdgfra in the developing lung mesenchyme.
For Etv conditional knockouts, Shhcre (Harfe et al., 2004), Etv4 and
Etv5 alleles (Laing et al., 2000; Zhang et al., 2009) were used.
PECAM mutants used have been described previously (DeLisser
et al., 2006).
5.2. Hyperoxic-exposure
Hyperoxic-exposure was conducted as previously described
(Balasubramaniam et al., 2007; Bozyk et al., 2012). Brieﬂy, Pdgfra-
GFP plugs were synchronized with Swiss Webster (SW) plugs. At
P1, each Pdgfra-GFP litter was separated into 2 groups and each
group was fostered by a SW mother. At P1, one group was placed
into a chamber circulating with 75% oxygen through P15. The
other group was maintained at normoxia (room air) conditions for
the duration of the experiment. Fostering mothers were swapped
between normoxia and hyperoxia litters every fourth day to
maintain maternal health. Lungs from both normoxia and hyper-
oxia groups were harvested at P15.
5.3. Immunhistochemistry and imaging
Lungs were gravity ﬁx-inﬂated with 4% paraformaldehyde, and
then submerged in ﬁx at 4 °C overnight. Whole lung lobes were
embedded in 4% low-melt agarose and sections of 75 um thickness
were prepared using a vibratome (Leica VT1000 S). Sections were
incubated overnight at 4 °C with the following primary antibodies:
rabbit anti-SPC [1:400] (Seven Hills Bioreagents), Syrian hamster
anti-T1alpha (podoplanin) [1:200] (Developmental Studies Hy-
bridoma Bank), SMA-Cy3 [1:500] (Sigma), Rb anti-elastin [1:400]
(a generous gift from Robert Mecham), Rat anti-PECAM (CD31)
[1:100] (BD Biosciences). Antibodies were diluted in a solution of
phosphate buffered saline containing 1% Triton-X as permeabili-
zation agent, which is also in washing solution. The following
secondary antibodies were used: goat anti-rabbit Cy3, goat anti-
rabbit FITC, goat anti-syrian hamster FITC, goat anti-syrian ham-
ster Cy3, goat anti-rat Cy3 (Jackson Immuno Research Labora-
tories) [1:400]. For lipid staining, LipidTOX™ (Invitrogen) was
used at 1:250. Sections were mounted in Vectashield (Vector La-
boratories) beneath a coverslip raised with small pieces of clay to
prevent compressing the tissues.
Immunostained tissues were observed with a confocal laser
scanning microscope LSM 510 (Carl Zeiss, Germany) equipped
with an argon laser (excitation 488 nm) and a DPS laser (excitation
561 nm). Serial optical sections were captured using a 40X Plan
Neoﬂuar oil objective with 1.30 numerical aperture over a total
depth of 50 um with a 0.5 um z-step. The xy plane resolution as
calculated by 0.4 X wavelength/numerical aperture is 150.1 for
green (488 nm) and 175 for red (570 nm). Three-dimensional re-
constructions and movies were generated using IMARIS analysis
software (Bitplane, Switzerland) with no averaging. Three-di-
mensional surface projections were rendered in IMARIS and
shown for visualization of lung architecture. At minimum, ﬁve
images of different sections from lungs of four animals were
compared for each stage and staining condition. For quantiﬁcation
of cells per alveolus, ten different lungs were used and 50 alveoli
were counted at minimum. Results were reported as the mean cell
number per alveolus7standard deviation.Acknowledgments
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